Skip to main content

Month: September 2020

Rizobacter and Marrone Bio Innovations form a Strategic Alliance to Deploy Novel Plant Health and Crop Nutrition Technology in South America

PERGAMINO, Argentina and DAVIS, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Rizobacter, a subsidiary of Bioceres Crop Solutions Corp. (NYSE: BIOX) and global leader in sustainable solutions for agriculture, and Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, announced the signing of an exclusive agreement to distribute a foliar fertilizer and plant health technology in Argentina, Uruguay, Paraguay and Bolivia.South America is well-known for its extensive soybean, corn and wheat production, crops where MBI’s technology will be an important tool in helping growers increase yield through improved nutrition and plant health. Demand for biologicals is increasing in the region with an estimated market value of USD 1 billion and a projected CAGR of 11%....

Continue reading

B2Digital Announces B2 Social Media Network Roars Back with Growing Fan and Customer Engagements

Tampa, FL, Sept. 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — B2Digital Incorporated (the “Company” or “B2Digital”) (OTCMKTS:BTDG), the premier development league for mixed martial arts (“MMA”), is pleased to report strong growth in its B2 Social Media Network (“B2SN”) on total engagement across the entire B2 Social Media Network.Highlights from the recent report from the two week period of August 24 through September 5:·         Over 72,000 Unique Engaged Users·         Over 2.4 million Social Media connections or at the same current rate in the next 90 days would be over 14 Million Social Media Connections to B2 content.·         Total Facebook “Reach” up over 412% monthly, with impressions up 400% in that time·         Fans and consumers directly viewed over 1,485 hours of the B2 Produced and Owned Content on the B2 Social...

Continue reading

MediXall Group Provides Update on the Launch of Health Karma™

Over 1 million physician profiles now in the database & connected to over 2,000 Health Insurance policies nationwide.FORT LAUDERDALE, Sept. 15, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — MediXall Group, Inc. (OTCQB: MDXL), a healthcare technology company based in Fort Lauderdale, Fla., today provided an update for the launch of Health Karma™, a free tool that will bring cost transparency, choice, and control to healthcare consumers regardless of insurance coverage.  The public launch of Health Karma™ remains on schedule for a November 2020 launch and will include the full set of features as well as the iOS and Android mobile app, providing consumers with the tools and information needed to make more informed decisions around their healthcare. While developing the Health Karma™ platform, the Company has accomplished the...

Continue reading

Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program

CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced 21 recipients of Route 79, The Duchenne Scholarship Program. This is the third year of the scholarship program, which was created to recognize exceptional individuals with Duchenne muscular dystrophy as they pursue their post-secondary education. Recipients were chosen by an independent selection committee composed of Duchenne community members, who consider each applicant’s community involvement and a personal essay. Each student will receive a scholarship of up to $5,000.“It is our great privilege to announce and congratulate the 2020 recipients of Route 79, The Duchenne Scholarship Program. With each new class of applicants, we are reminded of the varied interests,...

Continue reading

Prothena to Hold Investor Webcast to Discuss Results from Phase 2 PASADENA Study Presented at the International Parkinson and Movement Disorder Society’s MDS Virtual Congress

DUBLIN, Ireland, Sept. 15, 2020 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a clinical-stage company with expertise in protein dysregulation and a diverse pipeline of investigational therapeutics for neurodegenerative and rare peripheral amyloid diseases will hold an investor webcast today at 1:30 PM ET following Roche’s Top Abstract oral presentation of the clinical results from the Phase 2 PASADENA study today at the International Parkinson and Movement Disorder Society’s MDS Virtual Congress 2020 (MDS Congress).Both the Top Abstract oral presentation and the poster regarding PASADENA results from the ePoster Hall at the MDS Virtual Congress can be found on the MDS Virtual Congress website and also will be posted on www.prothena.com under the Investors tab in the Events and Presentations section following...

Continue reading

Fluidigm Announces Agenda for 9th Annual Mass Cytometry Summit

Virtual Event Showcases CyTOF Technology and Its Use in High-Parameter Suspension Mass Cytometry and Imaging Mass CytometryLeading Academic and Pharma Researchers Detail Latest CyTOF Based Discoveries in Infectious Disease, Immunology and the Tumor MicroenvironmentSOUTH SAN FRANCISCO, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the agenda for the 9th Annual Fluidigm Mass Cytometry Summit on September 23. The full-day, virtual event showcases CyTOF® technology and its use in high-parameter suspension mass cytometry and Imaging Mass Cytometry™.Each year, the Mass Cytometry Summit underscores the significant role that mass cytometry plays in immunology, immune function, immuno-oncology...

Continue reading

Mexican Gold Announces Initial Results From 10,000 Metre Drill Program

VANCOUVER, British Columbia, Sept. 15, 2020 (GLOBE NEWSWIRE) — Mexican Gold Mining Corp. (the “Company” or “Mexican Gold”) (TSXV: MEX) is pleased to announce initial assay results from the 2020 drilling program, which targeted expansion and definition drilling at the existing resource at El Dorado.  Drilling is ongoing.Highlights:Mexican Gold has drilled 29 holes for 4,031m, targeting various potential zones of extension of the existing resource at El Dorado, which remains open in several directionsStep-outs of between 90m and 135m carry the El Dorado zone further west over a 450m length. Assays include 10m of 3.93 g/t AuEq in hole LM-20-JB-29 and 19m of 2.15 g/t AuEq in hole LM-20-JB-33The El Dorado resource has tentatively been opened to the south with holes LM-20-ED-60 at 30.4m of 4.00 g/t AuEq and LM-20-JB-30 at 16m of...

Continue reading

Sustainable Green Team, Ltd. (SGTM) Forms Strategic Alliance with Tree Leads Today to Expand National Partnerships, Obtain Contracts Beyond Central Florida Arborcare’s Reach

ORLANDO, Fla., Sept. 15, 2020 (GLOBE NEWSWIRE) — Sustainable Green Team, Ltd. (OTC: SGTM) (“SGTM” or the “Company”), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announces that its wholly owned subsidiary, National Storm Recovery, LLC (“NSR”), has formed a strategic alliance with Tree Leads Today (“TLT”) to expand national partnerships and obtain contracts beyond SGTM’s wholly owned subsidiary, Central Florida Arborcare’s, reach. This strategic alliance was formed when NSR deployed its team to assess damages from Hurricane Laura, and it was TLT that assisted in the partnership with ArborPro of Mississippi, Inc. on the recovery contract in the city of Sulphur, Louisiana.TLT is a nationwide, privately held company and an industry leader in the tree care marketing sector. Their...

Continue reading

Aerpio Announces Enrollment Completed in the 28-Day Phase 2 Razuprotafib Glaucoma Trial

CINCINNATI, Sept. 15, 2020 (GLOBE NEWSWIRE) — Aerpio Pharmaceuticals, Inc.(“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, as well as other indications in which the Company believes that activation of Tie2 may have therapeutic potential, including acute respiratory distress syndrome (“ARDS”) associated with COVID-19 infections, today announced that it has completed patient enrollment in its double-blind, placebo-controlled Phase 2 trial in patients with elevated intraocular pressure (IOP) associated with open angle glaucoma (OAG) or ocular hypertension (OHT).The study is designed to evaluate the safety and efficacy of a topical ocular formulation of razuprotafib in approximately 195 patients followed over a 28-day...

Continue reading

Fibonacci Brands Acquires Darwin from Harvest Health and Recreation

SCOTTSDALE, Ariz., Sept. 15, 2020 (GLOBE NEWSWIRE) — Fibonacci Brands, ­a trusted player in the rapidly expanding international cannabis industry with a vision to create a house of world-class brands, today announces its acquisition of Darwin from Harvest Health and Recreation as the foundation brand of Fibonacci Brands.“We are thrilled with the opportunity to execute the vision of Darwin: to reintroduce humanity to cannabis, with integrity, so everyone can ‘Enjoy with Confidence,’” says Fibonacci Brands founder James George. “We thank everyone who has supported Darwin over the years, and we are excited to evolve our products to make Darwin even more accessible to the cannabis community.”Darwin was housed under AZ Natural Selections prior to its acquisition by Harvest Health and Recreation. Its products include Caramel Hard Candies,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.